Joseph Gilliam
President presso GLAUKOS CORPORATION
Patrimonio netto: 10 M $ in data 31/03/2024
Profilo
Joseph E.
Gilliam's current jobs include being a Director at Avedro, Inc. since 2019, a Director at Caris Life Sciences, LLC since 2021, and the President & Chief Operating Officer at Glaukos Corp.
since 2017.
Previously, he worked as a Managing Director-Healthcare Investment Banking at JPMorgan Chase & Co. from 2001 to 2017.
He completed his undergraduate degree at Kelley School of Business in 1998.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
GLAUKOS CORP
0.21% | 08/04/2024 | 101 845 ( 0.21% ) | 10 M $ | 31/03/2024 |
Posizioni attive di Joseph Gilliam
Società | Posizione | Inizio |
---|---|---|
GLAUKOS CORPORATION | President | 01/04/2022 |
AVEDRO, INC. | Director/Board Member | 21/11/2019 |
Caris Life Sciences, LLC
Caris Life Sciences, LLC Medical/Nursing ServicesHealth Services Caris Life Sciences Ltd. provides diagnostics and anatomic pathology services. The firm develops an unbiased profiling platform for novel target identification, drug development and delivery, diagnostic and disease monitoring, and precision medicine enabling aspects. It offers services throughout the U.S., Europe, Australia and other international markets. The company was founded by David D. Halbert in 2008 and is headquartered in Irving, TX. | Director/Board Member | 12/04/2021 |
Precedenti posizioni note di Joseph Gilliam
Società | Posizione | Fine |
---|---|---|
JPMORGAN CHASE & CO. | Corporate Officer/Principal | 01/05/2017 |
Formazione di Joseph Gilliam
Kelley School of Business | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
JPMORGAN CHASE & CO. | Finance |
GLAUKOS CORPORATION | Health Technology |
Aziende private | 2 |
---|---|
Avedro, Inc.
Avedro, Inc. Medical SpecialtiesHealth Technology Avedro, Inc. develops ophthalmic medical devices and pharmaceutical products. The firm’s products include KXL System, Mosaic system, IROC system and Riboflavin family. Its procedure includes Lasic Xtra, accelerated cross-linking and photorefractive intrastromal cross-linking. The company was founded by David F. Muller and B. Stuart Trembly on November 6, 2002 and is headquartered in Waltham, MA. | Health Technology |
Caris Life Sciences, LLC
Caris Life Sciences, LLC Medical/Nursing ServicesHealth Services Caris Life Sciences Ltd. provides diagnostics and anatomic pathology services. The firm develops an unbiased profiling platform for novel target identification, drug development and delivery, diagnostic and disease monitoring, and precision medicine enabling aspects. It offers services throughout the U.S., Europe, Australia and other international markets. The company was founded by David D. Halbert in 2008 and is headquartered in Irving, TX. | Health Services |
- Borsa valori
- Insiders
- Joseph Gilliam